Registry collecting data on patients undergoing heart artery procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Naples PCI Registry aims to gather prospective data on the clinical, laboratory, and angiographic characteristics of patients undergoing percutaneous coronary intervention (PCI) for coronary artery disease. This observational study will follow patients during their hospital stay and at a one-year follow-up to assess various clinical outcomes, including death, myocardial infarction, and other cardiovascular events. The registry will evaluate both stent-based and non-stent-based interventions, with all adverse events independently reviewed by a clinical events committee.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Clinical evidence of coronary artery disease requiring PCI;
2. Age ≥18 years;
3. Written informed consent.

Exclusion Criteria:

1\. Inability to provide informed consent.

Where it's running

• Department of Advanced Biomedical Sciences
  Naples, Italy Recruiting

Study contacts

• Study coordinator: Giovanni Esposito, MD, PhD
• Email: espogiov@unina.it
• Phone: +390817463075

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing a new medication to standard treatment for preventing stomach issues in heart patients on blood thinners

  This study is testing a new medication called tegoprazan to see if it can prevent stomach problems just as well as the standard treatment for heart patients who are taking blood thinners.

  Recruiting at 36 sites Phase 4 Asan Medical Center · Anyang and 44 other locations · NCT04416581

• Registry for patients undergoing angioplasty in Korea

  This study is collecting information from patients who have had angioplasty to help understand how well the treatment works in real life.

  Recruiting Yonsei University · Seoul · NCT03908463

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients

  This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.

  Recruiting Fondazione Ricerca e Innovazione Cardiovascolare ETS · Milan, MI · NCT06535568

• Understanding sex hormones and inflammation in heart disease

  This study looks at how sex hormones and inflammation affect heart disease in women to better understand their unique risks and improve treatment.

  Recruiting Queen Mary University of London · London · NCT06327984

• Investigating risk factors in patients with acute coronary syndrome undergoing a procedure

  This study is trying to find out what risk factors affect patients with acute coronary syndrome who are having a heart procedure and how these factors relate to their health outcomes over two years.

  Recruiting Jinan Central Hospital · Jinan, Shandong · NCT05719545

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.